Poster: CLL-035 Long-term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
Mustafa, Shokhan Mohammad, Yassin, Ahmed Khudair, Mohammed, Nawsherwan S., Shamoon, Rawand P., Karma, Marwa N., Mohammad, Shlan S., Abdulrahman, Lara Lateef, Ahmed, Zhalla O., Rashid, Bryar Sabah, Mahmood, Tavan I., Yousif, Rozhhat A., Hasan, Kawa M., Mohamed, Zaki A., Getta, Hisham A., Jalal, Sana D., Abdullah, Dana A., Abdulla, Basil K., Numan, Ghanim S., Karadagh, Ranan
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
CLL-035 Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
Mustafa, Shokhan Mohammad, Yassin, Ahmed Khudair, Mohammed, Nawsherwan S., Shamoon, Rawand P., Karma, Marwa N., Mohammad, Shlan S., Abdulrahman, Lara Lateef, Ahmed, Zhalla O., Rashid, Bryar Sabah, Mahmood, Tavan I., Yousif, Rozhhat A., Hasan, Kawa M., Mohamed, Zaki A., Getta, Hisham A., Jalal, Sana D., Abdullah, Dana A., Abdulla, Basil K., Numan, Ghanim S., Karadagh, Ranan
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article